Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs. (2020)

First Author: Kaye PM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00281-020-00788-y

PubMed Identifier: 32152715

Publication URI: http://europepmc.org/abstract/MED/32152715

Type: Journal Article/Review

Volume: 42

Parent Publication: Seminars in immunopathology

Issue: 3

ISSN: 1863-2297